Puma Biotechnology, Inc.PBYINASDAQ
Loading
Year-over-year SG&A expense growth
Latest
-11.62%
↓ 184% vs avg
Percentile
P21
Within normal range
Streak
2 yr
Consecutive declineDecelerating
Average
13.80%
Historical baseline
| Period | Value |
|---|---|
| 2025 | -11.62% |
| 2024 | -10.24% |
| 2023 | -0.74% |
| 2022 | -22.63% |
| 2021 | -1.85% |
| 2020 | -16.35% |
| 2019 | -3.12% |
| 2018 | 37.02% |
| 2017 | 98.33% |
| 2016 | 69.18% |